A new post by Kirill Osipov in the Kluwer Patent Blog May 18, 2026 Kluwer Patent Blog, an international web source dedicated to patent law, published a new post by Kirill Osipov, the Head of Legal Department at ARS-Patent. The article is a continuation of the previous post from July 25, 2025, and addressed to two patent disputes involving patented medicines: osimertinib and axitinib. Both cases, which centre on generic products and allegations of unfair competition, were resolved by decisions of the Federal Antimonopoly Service (FAS). The axitinib case is particularly noteworthy as a landmark precedent: the decision was upheld by the Russian Supreme Court, which ruled in favor of the FAS and the originator company. Read the details of these cases in Kirill’s post here Make an enquiry
MEET WITH US ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read moreARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read moreSee all Events
ARS-Patent will attend the APAA 2025 in Kuala Lumpur2025-10-03We are pleased to announce that ARS-Patent will be a part of the upcoming global IP event APAA 2025, which is the 21st General Assembly and 77th & 78t...Read more
ARS-Patent at AIPPI World Congress 2025 in Yokohama2025-08-18The AIPPI World Congress 2025, which will be held in Yokohama, Japan, from September 13-16, will be a significant international gathering for intellec...Read more
